ACCESS A Master Digital Surveillance Protocol for COVID-19

Completed

Conditions studied: Coronavirus, COVID, COVID-19, COVID19, Corona Virus Infection, Coronavirus Infection

In brief

ACCESS enables individuals to contribute to critical research, via an iOS and Android smartphone mobile application. ACCESS combines patient reported outcomes, data from wearable devices and real-world data (such as claims, EHRs, etc), with an opt-in to participate in current and future studies for diagnostics, treatments and vaccines. The data that people share can be quickly and anonymously matched to research studies, providing researchers with a foundational framework for dynamic research at scale and participants a way to be personally matched and prescreened for future research.

Key facts

Study ID

NCT04363268

Run by

Medable Inc.

People needed

260

Starts

2020-04-20

Expected to finish

2022-12-31

Last updated by the study team

2023-05-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18 years or older
• Able to provide electronic informed consent
• US Resident
• Read and comprehend English

You may not qualify if…

• Do not have a personal smartphone

Where it is running

• Medable Inc. — Palo Alto, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.